Dimerix Limited

ASX (AUD): Dimerix Limited (DXB)

Last Price

0.487

Today's Change

+0.007 (1.45%)

Day's Change

0.465 - 0.515

Trading Volume

5,728,784

Overview

Market Cap

273 Million

Shares Outstanding

557 Million

Avg Volume

2,001,386

Avg Price (50 Days)

0.36

Avg Price (200 Days)

0.41

PE Ratio

-12.25

EPS

-0.04

Earnings Announcement

24-Feb-2025

Previous Close

0.48

Open

0.47

Day's Range

0.465 - 0.515

Year Range

0.16 - 0.665

Trading Volume

5,800,490

Price Change Highlight

1 Day Change

2.08%

5 Day Change

42.03%

1 Month Change

38.03%

3 Month Change

28.95%

6 Month Change

7.69%

Ytd Change

31.54%

1 Year Change

60.66%

3 Year Change

60.66%

5 Year Change

60.66%

10 Year Change

60.66%

Max Change

60.66%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment